Intravenous bisphosphonates for postmenopausal osteoporosis.
about
Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis.Current Clinical Practice Scenario of Osteoporosis Management in IndiaCost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment.Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro.
P2860
Intravenous bisphosphonates for postmenopausal osteoporosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intravenous bisphosphonates for postmenopausal osteoporosis.
@ast
Intravenous bisphosphonates for postmenopausal osteoporosis.
@en
Intravenous bisphosphonates for postmenopausal osteoporosis.
@nl
type
label
Intravenous bisphosphonates for postmenopausal osteoporosis.
@ast
Intravenous bisphosphonates for postmenopausal osteoporosis.
@en
Intravenous bisphosphonates for postmenopausal osteoporosis.
@nl
prefLabel
Intravenous bisphosphonates for postmenopausal osteoporosis.
@ast
Intravenous bisphosphonates for postmenopausal osteoporosis.
@en
Intravenous bisphosphonates for postmenopausal osteoporosis.
@nl
P2860
P1476
Intravenous bisphosphonates for postmenopausal osteoporosis.
@en
P2093
Peyman Mottaghi
P2860
P304
P577
2010-05-01T00:00:00Z